Our Client is seeking a highly motivated and team-oriented candidate for the 
position of Scientist in the Drug Metabolism and Pharmacokinetics (DMPK) 
Department. The successful applicant will lead the development, validation, and 
application of cell based in vitro ADME assays to support our discovery and 
development programs. Reporting directly to the Senior Director of Clin Pharm, 
this is a unique opportunity to take on a role with a broad range of 
responsibilities and work in DMPK and Clinical Pharmacology.

Core responsibilities:

Utilize animal models, define efficacy, pharmacodynamics and translational 
principles for selection of development candidate molecules Conducts the 
analysis, interpretation and reporting of clinical and non-clinical 
pharmacokinetic data.
Helps plan, conducts and reports quantitative analyses to select / optimize 
doses, dosage regimens throughout clinical drug development Experience with 
Simcyp, Monolix, Phoenix Winnonlin or other modeling software. PBPK experience 
and experience with DDI is crucial

Qualifications:

Must have 2+ years of experience in the pharma/ biotechnology industry or Post 
Doc. Ph.D./PharmD in Pharmacology, Biomedical Sciences, Pharmacokinetics or 
other discipline with appropriate experience Strong, demonstrable track record 
of scientific leadership excellence Demonstrated small molecule drug discovery 
experience: track-record of advancing multiple novel therapeutic agents from 
discovery into preclinical and subsequent clinical development as project team 
leader or member Experience in successfully selecting and managing CROs to 
provide high quality, timely and on-budget studies




For more information please contact:

TJ Elder
Search Consultant
Pre-Clinical Development
O: 413.458.6124
C: 413.207.7676
https://www.linkedin.com/in/tjelder/
[email protected]<mailto:[email protected]>


[cid:[email protected]]<http://www.stem-sourcing.com/>

Please Note:
The information in this e-mail message is legally privileged and confidential 
information intended only for the use of the addressee(s) named above.  If you, 
the reader of this message, are not the intended recipient, you are hereby 
notified that you should not further disseminate, distribute, or forward this 
e-mail message.  If you have received this e-mail in error, please notify the 
sender as soon as possible.  In addition, please delete the erroneously 
received message from any device/media where the message is stored.

Reply via email to